1
B-Complex with L-Lysine Syrup (For therapeutic use)
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Thiamine Hydrochloride
I.P.
2 mg
Riboflavine Sodium Phosphate
I.P.
2.5 mg
Pyridoxine Hydrochloride
I.P.
0.75 mg
Nicotinamide
I.P.
15 mg
D-Panthenol
I.P.
3 mg
Cyanocobalamin
I.P.
2 mcg
Lysine Hydrochloride
I.P.
375 mg
Zinc Gluconate (eq. to elemental Zinc)
USP
5 mg
Sorbitol Solution 70% (Non-crystallizing)
I.P.
q.s.
In a flavoured syrupy base
q.s.
Excipients
q.s.
Colour: Approved colour used
2
Dextromethorphan Hydrobromide, Chlorpheniramine Maleate Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Dextromethorphan Hydrobromide
I.P.
5 mg
Chlorpheniramine Maleate
I.P.
2 mg
Excipients
q.s.
In a flavoured syrupy base
q.s.
Approved Colour used
3
Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylepherine Hydrochloride Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Dextromethorphan Hydrobromide
I.P.
15 mg
Chlorpheniramine Maleate
I.P.
2 mg
Phenylepherine Hydrochloride
I.P.
5 mg
Excipients
q.s.
In a palatable sugar-free base
q.s.
Approved Colour used
4
Domperidone Oral Drop
Composition
Standard
Quantity (per 1 ml)
Each 1 ml contains :
Domperidone
I.P.
10 mg
Excipients
q.s.
In a flavoured syrupy base
q.s.
Approved Colour used
5
Ambroxol HCl, Dextromethorphan HBR, Phenylepherine HCl, Chlorpheniramine Maleate and Menthol Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ambroxol Hydrochloride
I.P.
15 mg
Dextromethorphan Hydrobromide
I.P.
10 mg
Phenylephrine Hydrochloride
I.P.
5 mg
Chlorpheniramine Maleate
I.P.
2 mg
Menthol
I.P.
1.5 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
6
Dried Aluminium Hydroxide Gel, Oxetacaine and Magnesium Hydroxide Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Aluminium Hydroxide (added as Dried Aluminium Hydroxide Gel 380 mg)
I.P.
0.291 gm
Oxetacaine
B.P.
10 mg
Magnesium Hydroxide (as Magnesium Hydroxide Paste)
I.P.
98 mg
Excipients
q.s.
In a flavoured palatable base
q.s.
Approved colour used
7
Levosalbutamol Sulphate, Ambroxol Hydrochloride, and Guaiphenesin Oral Drops
Composition
Standard
Quantity (per 1 ml)
Each 1 ml contains :
Levosalbutamol Sulphate (eq. to Levosalbutamol)
I.P.
0.25 mg
Ambroxol Hydrochloride
I.P.
7.5 mg
Guaiphenesin
I.P.
12.5 mg
Excipients
q.s.
In a flavoured syrupy base
q.s.
Approved Colour used
8
Cyproheptadine Hydrochloride and Tricholine Citrate Drops
Composition
Standard
Quantity (per 1 ml)
Each 1 ml contains :
Cyproheptadine Hydrochloride
I.P.
2 mg
Tricholine Citrate (65%)
55 mg
Excipients
q.s.
In a flavoured syrupy base
q.s.
Approved Colour used
9
Ursodeoxycholic Acid Suspension 250mg
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ursodeoxycholic Acid
I.P.
250 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
10
Ursodeoxycholic Acid Suspension 125mg
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ursodeoxycholic Acid
I.P.
125 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
11
Paracetamol, Phenylephrine HCl, Chlorpheniramine Maleate, Sodium Citrate and Menthol syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol
I.P.
125 mg
Phenylephrine Hydrochloride
I.P.
5 mg
Chlorpheniramine Maleate
I.P.
0.5 mg
Sodium Citrate
I.P.
60 mg
Menthol
I.P.
1 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
12
Milk of Magnesia, Liquid Paraffin and Sodium Picosulfate oral emulsion
Composition
Standard
Quantity (per 5 ml)
Each 5 ml (1 teaspoonful approx.) contains :
Milk of Magnesia
I.P.
3.75 ml
Liquid Paraffin
I.P.
1.25 ml
Sodium Picosulfate
B.P.
3.33 mg
Excipients
q.s.
Indication
For symptomatic treatment of constipation in adults
Dosage
As directed by the physician
Approved colour used
13
Ferric Ammonium Citrate, Folic acid and Vitamin B12 Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ferric Ammonium Citrate (eq. to Elemental Iron)
I.P.
160 mg (Elemental Iron 32.80 mg)
Folic Acid
I.P.
0.5 mg
Cyanocobalamin
I.P.
7.5 mcg
Excipients
q.s.
In a flavoured syrupy base
q.s.
Colour
Approved colour used
14
Ofloxacin & Metronidazole Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ofloxacin
I.P.
100 mg
Metronidazole Benzoate (eq. to Metronidazole)
I.P.
200 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
15
Azithromycin Oral Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Azithromycin (as dehydrate) eq. to Azithromycin anhydrous
I.P.
100 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
16
Dill Oil, Fennel Oil with Simethicone Oral Drops
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Dill Oil
B.P.
0.005 ml
Fennel Oil
USP
0.0007 ml
Simethicone Emulsion (30%) eq. to Simethicone
USP
40 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
17
Zinc Gluconate Oral Solution
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Zinc Gluconate (eq. to elemental Zinc)
B.P.
20 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
18
Paracetamol Suspension I.P. 500 mg
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol
I.P.
500 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
19
Levetiracetam Oral Solutions I.P 500mg
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Levetiracetam
I.P.
500 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
20
Ambroxol Hydrochloride Syrup 30mg
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ambroxol Hydrochloride
I.P.
30 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
21
Ranitidine Oral Solution I.P
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ranitidine Hydrochloride (eq. to Ranitidine)
I.P.
75 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
22
Ibuprofen and Paracetamol Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ibuprofen
I.P.
100 mg
Paracetamol
I.P.
162.5 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
23
Hydroxyzine Oral Solution I.P.
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Hydroxyzine Hydrochloride
I.P.
10 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
24
Paracetamol, Phenylephrine HCl, Chlorpheniramine Maleate, Sodium Citrate and Menthol Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol
I.P.
125 mg
Phenylephrine Hydrochloride
I.P.
5 mg
Chlorpheniramine Maleate
I.P.
0.5 mg
Sodium Citrate
I.P.
60 mg
Menthol
I.P.
1 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
25
Fexofenadine Hydrochloride Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Fexofenadine Hydrochloride
I.P.
60 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
26
Fexofenadine Hydrochloride Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Fexofenadine Hydrochloride
I.P.
30 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
27
Phenylepherine Hydrochloride & Chlorpheniramine Maleate Syrup I.P
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Phenylephrine Hydrochloride
I.P.
5 mg
Chlorpheniramine Maleate
I.P.
2 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
28
Iron, Vitamin B12 and Folic Acid Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ferric Ammonium Citrate (eq. to elemental Iron)
I.P.
110.55 mg
Folic Acid
I.P.
1.5 mg
Cyanocobalamin
I.P.
15 mcg
In a flavoured syrupy base
q.s.
Excipients
q.s.
Colour: Approved colour used
29
Pyridoxine Hydrochloride, Nicotinamide, Cyanocobalamin and Lysine Hydrochloride Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Pyridoxine Hydrochloride
I.P.
0.75 mg
Nicotinamide
I.P.
15 mg
Cyanocobalamin
I.P.
2 mcg
Lysine Hydrochloride
I.P.
37.5 mg
In a flavoured syrupy base
q.s.
Excipients
q.s.
Colour: Approved colour used
30
Liquid Paraffin & Milk of Magnesia Suspension
Composition
Standard
Quantity (per 15 ml)
Each 15 ml contains :
Liquid Paraffin
I.P.
3.75 ml
Milk of Magnesia
I.P.
11.25 ml
Excipients
q.s.
In a flavoured syrupy base
q.s.
Approved colour used
31
Promethazine Syrup I.P
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Promethazine Hydrochloride
I.P.
5 mg
Excipients
q.s.
In a flavoured syrupy base
q.s.
Approved colour used
32
Levocetirizine Dihydrochloride Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Levocetirizine Dihydrochloride
I.P.
2.5 mg
Excipients
q.s.
In a flavoured syrupy base
q.s.
Approved colour used
33
Levodropropizine & Chlorpheniramine Maleate Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Levodropropizine
I.P.
30 mg
Chlorpheniramine Maleate
I.P.
2 mg
Excipients
q.s.
Approved Colour used
34
Diphenhydramine HCl, Ammonium Chloride, Sodium Citrate and Menthol Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Diphenhydramine Hydrochloride
I.P.
14.08 mg
Ammonium Chloride
I.P.
138 mg
Sodium Citrate
I.P.
57.03 mg
Menthol
I.P.
1.14 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
35
Potassium Citrate, Magnesium Citrate & Pyridoxine HCl Oral Solution
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Potassium Citrate
I.P.
1100 mg
Magnesium Citrate
USP
375 mg
Pyridoxine Hydrochloride
I.P.
20 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
36
Calcium, Magnesium, Zinc & Vitamin D3 Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Calcium Carbonate (eq. to elemental Calcium)
I.P.
625 mg
Magnesium Hydroxide (eq. to elemental Magnesium)
I.P.
75 mg
Zinc Gluconate (eq. to elemental Zinc)
USP
2 mg
Vitamin D3
I.P.
200 I.U.
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
37
Sodium Alginate, Sodium Bicarbonate and Calcium Carbonate Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Sodium Alginate
I.P.
250 mg
Sodium Bicarbonate
I.P.
133.5 mg
Calcium Carbonate
I.P.
80 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
38
Dried Aluminium Hydroxide, Magnesium Hydroxide, Simethicone Suspension
Composition
Standard
Quantity (per 10 ml)
Each 10 ml contains :
Dried Aluminium Hydroxide
I.P.
250 mg
Magnesium Hydroxide
I.P.
250 mg
Simethicone
I.P.
50 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
39
Chlorhexidine Gluconate Mouth Wash IP
Composition
Standard
Quantity
Chlorhexidine Gluconate
I.P.
0.2% w/v
In a pleasantly flavoured syrupy base
q.s.
Approved colour used
40
Paracetamol, Cetirizine HCl, Phenylephrine HCl and Menthol Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol
I.P.
250 mg
Cetirizine Hydrochloride
I.P.
2.5 mg
Phenylephrine Hydrochloride
I.P.
2.5 mg
Menthol
I.P.
1 mg
Excipients
q.s.
In a flavoured syrupy base
q.s.
Approved colour used
41
Cetirizine HCl, Phenylephrine HCl and Paracetamol Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Cetirizine Hydrochloride
I.P.
2.5 mg
Phenylephrine Hydrochloride
I.P.
5 mg
Paracetamol
I.P.
125 mg
Excipients
q.s.
In a flavoured syrupy base
q.s.
Approved colour used
42
Levocloperastine Fendizoate Oral Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Levocloperastine Fendizoate (eq. to Levocloperastine Hydrochloride)
20 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
43
Paracetamol, Phenylephrine & Chlorpheniramine Maleate Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol
I.P.
250 mg
Phenylephrine Hydrochloride
I.P.
5 mg
Chlorpheniramine Maleate
I.P.
2 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
44
Fungal Diastase and Pepsin Syrup
Composition
Standard
Quantity (per 15 ml)
Each 15 ml contains :
Fungal Diastase (1:1200) (Derived from Aspergillus oryzae, digest not less than 60 gm of cooked starch)
I.P.
50 mg
Pepsin (1:3000) (Digest not less than 60 gm of coagulated egg albumin)
I.P.
10 mg
Excipients
q.s.
In a Flavoured Palatable base
q.s.
Approved Colour used
Dosage:
Adult: One teaspoonful immediately after the meal.
Children: Half the adult dose.
As directed by the physician.
45
Sucralfate and Oxetacaine Suspension
Composition
Standard
Quantity (per 10 ml)
Each 10 ml contains :
Sucralfate
USP
1000 mg
Oxetacaine
B.P.
20 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
46
Lactulose Oral Solution U.S.P.
Composition
Standard
Quantity (per 15 ml)
Each 15 ml contains :
Lactulose Concentrate (eq. to Lactulose 66% w/v)
USP
10 gm
In a flavoured syrup base
q.s.
Excipients
q.s.
Approved colour used
47
Mefenamic Acid and Paracetamol Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Mefenamic Acid
I.P.
100 mg
Paracetamol
I.P.
250 mg
In Flavoured syrup base
q.s.
Approved colour used
48
Di-Sodium Hydrogen Citrate Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Di-Sodium Hydrogen Citrate
B.P.
1.37 gm
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
49
Ofloxacin, Metronidazole Benzoate and Simethicone Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ofloxacin
I.P.
50 mg
Metronidazole Benzoate (eq. to Metronidazole)
I.P.
120 mg
Simethicone
I.P.
10 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
50
Sodium Picosulfate Oral Solution B.P.
Composition
Standard
Quantity (per 5 ml)
Each 5 ml (1 teaspoonful approx.) contains :
Sodium Picosulfate
B.P.
5 mg
Excipients
q.s.
Dosage: As directed by the physician.
Approved Colour used
51
Milk of Magnesia, Liquid Paraffin and Sodium Picosulfate oral emulsion
Composition
Standard
Quantity (per 5 ml)
Each 5 ml (1 teaspoonful approx.) contains :
Sodium Picosulfate
B.P.
33.3 mg
Liquid Paraffin
I.P.
1.25 ml
Milk of Magnesia
I.P.
3.75 ml
Excipients
q.s.
Indication: For symptomatic treatment of constipation in adults.
Dosage: As directed by the physician.
Approved Colour used
52
Dried Aluminium Hydroxide, Magnesium Hydroxide, Simethicone and Oxetacaine Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Dried Aluminium Hydroxide Gel (eq. to Aluminium Hydroxide)
I.P.
600 mg
Magnesium Hydroxide
I.P.
300 mg
Simethicone
I.P.
25 mg
Oxetacaine
B.P.
10 mg
Purified Water
I.P.
q.s.
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
53
Ofloxacin Oral Suspension I.P. 100mg
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ofloxacin
I.P.
100 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
54
Ondansetron Oral Solution I.P. 2 mg
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ondansetron Hydrochloride (eq. to Ondansetron)
I.P.
2 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
55
Paracetamol Paediatric Oral Suspension I.P. 250mg
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol
I.P.
250 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
56
Paracetamol Paediatric Oral Suspension I.P. 125mg
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Paracetamol
I.P.
125 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
57
Magaldrate and Simethicone Oral Suspension I.P.
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Magaldrate (Anhydrous)
I.P.
400 mg
Simethicone
I.P.
60 mg
In a suspension base
Excipients
q.s.
Approved Colour used
58
Mefenamic Acid and Paracetamol Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Mefenamic Acid
I.P.
50 mg
Paracetamol
I.P.
125 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
59
Vitamin D3 oral Solution 60000 I.U (Nano Shot)
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Cholecalciferol (Vitamin D3) (In nano droplet form)
I.P.
60,000 I.U.
In a flavoured sorbitol base
q.s.
Colour: Tartrazine Supra
60
Ambroxol Hydrochloride, Levosalbutamol Sulphate and Guaiphenesin Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ambroxol Hydrochloride
I.P.
15 mg
Levosalbutamol Sulphate (eq. to Levosalbutamol)
I.P.
0.50 mg
Guaiphenesin
I.P.
50 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
61
Lycopene Enriched with Antioxidants, Multivitamin and Multimineral Syrup
Composition
Standard
Quantity (per 10 ml)
Each 10 ml contains :
Lycopene 10%
USP
2000 mcg
Niacinamide
I.P.
25 mg
Folic Acid
I.P.
100 mcg
Selenium Dioxide Monohydrate (eq. to Selenium)
B.P.
35 mcg
Zinc (as Zinc Gluconate USP)
3 mg
Iodine (as Potassium Iodide IP)
100 mcg
Copper (as Cupric Sulphate USP)
500 mcg
Vitamin B12
I.P.
1 mcg
Vitamin B6
I.P.
1.5 mg
Excipients
q.s.
In a flavoured base
q.s.
Appropriate overages of vitamins added to compensate for any loss on storage
Approved colour used
62
Aceclofenac and Paracetamol Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Aceclofenac
I.P.
50 mg
Paracetamol
I.P.
125 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
63
Calcium Citrate Malate, Magnesium, Zinc,Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5 Phosphate Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Calcium Citrate Malate (eq. to elemental Calcium)
I.P.
1250/250 mg
Magnesium Hydroxide (eq. to elemental Magnesium)
I.P.
75 mg
Zinc Sulphate Monohydrate (eq. to elemental Zinc)
I.P.
5 mg
Vitamin D3 (as stabilized)
I.P.
2000 IU
Methylcobalamin
I.P.
1500 mcg
L-Methylfolate Calcium
USP
1 mg
Pyridoxal-5 Phosphate
20 mg
Excipients
q.s.
Approved colour used
64
Vitamin D3 (Cholecalciferol) Drops
Composition
Standard
Quantity (per ml)
Each 1 ml contains :
Vitamin D3 (Cholecalciferol)
I.P.
800 IU
Excipients
q.s.
In a flavoured Palatable base
q.s.
Approved Colour used
65
Fungal Diastase and Pepsin syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Fungal Diastase (1:1200) (Derived from Aspergillus oryzae, digest not less than 60 gm of cooked starch)
I.P.
50 mg
Pepsin (1:3000) (Digest not less than 60 gm of coagulated egg albumin)
I.P.
10 mg
Excipients
q.s.
In a Flavoured Palatable base
q.s.
Approved Colour used
Dosage:
Adult: One teaspoonful immediately after the meal.
Children: Half the adult dose.
As directed by the physician.
66
Clarithromycin Tablets I.P. 500 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Clarithromycin
I.P.
500 mg
Excipients
q.s.
Approved Colour used
67
Azithromycin Oral Suspension I.P.
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Azithromycin Dihydrate (eq. to anhydrous Azithromycin)
I.P.
200 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
68
Cilnidipine Tablets I.P 10 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Cilnidipine
I.P.
10 mg
Excipients
q.s.
Approved Colour used
69
Ferrous Ascorbate And Folic Acid Suspension
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ferrous Ascorbate (eq. to elemental iron)
30 mg
Folic Acid
I.P.
550 mcg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
70
Linagliptin Tablets 5 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Linagliptin
5 mg
Excipients
q.s.
Approved Colour used
71
Terbutaline Sulphate, Bromhexine Hydrochloride, Guiaphenesin and Menthol Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml (one teaspoonful) contains :
Terbutaline Sulphate
I.P.
1.25 mg
Bromhexine Hydrochloride
I.P.
4 mg
Guaiphenesin
I.P.
50 mg
Menthol
I.P.
1 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
72
Sitagliptin Phosphate Tablets I.P 100mg
Composition
Standard
Quantity
Each film coated tablet contains :
Sitagliptin Phosphate Monohydrate (Eq. to Sitagliptin)
I.P.
100 mg
Excipients
q.s.
Approved Colour used
73
Piracetam Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Piracetam
I.P.
500 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
74
Sitagliptin Phosphate Tablets I.P 50mg
Composition
Standard
Quantity
Each film coated tablet contains :
Sitagliptin Phosphate Monohydrate (Eq. to Sitagliptin)
I.P.
50 mg
Excipients
q.s.
Approved Colour used
75
Febuxostat Tablets 20 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Febuxostat
20 mg
Excipients
q.s.
Approved Colour used
76
Fenofibrate Tablets I.P 160 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Fenofibrate
I.P.
160 mg
Excipients
q.s.
Approved colour used
77
Montelukast Sodium and Levocetirizine Dihydrochloride Suspension (For Paediatric Use Only)
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Montelukast Sodium (eq. to Montelukast)
I.P.
4 mg
Levocetirizine Dihydrochloride
I.P.
2.5 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Colour: Approved colour used
78
Fenofibrate Tablets I.P 145mg
Composition
Standard
Quantity
Each film coated tablet contains :
Fenofibrate
I.P.
145 mg
Excipients
q.s.
Approved colour used
79
Etamsylate & Tranexamic Acid Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Etamsylate
B.P.
250 mg
Tranexamic Acid
I.P.
250 mg
Excipients
q.s.
Approved Colour used
80
Amlodipine Besylate and Metoprolol Succinate (ER)Tablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Amlodipine Besylate (Eq. to Amlodipine)
I.P.
5 mg
Metoprolol Succinate (eq. to Metoprolol Tartrate, Extended Released)
I.P.
23.75 mg/25 mg
Excipients
q.s.
Approved Colour used
81
Ferrous Ascorbate & Folic Acid Tablets I.P
Composition
Standard
Quantity
Each film coated tablet contains :
Ferrous Ascorbate (eq. to elemental iron)
I.P.
100 mg
Folic Acid
I.P.
1.5 mg
Excipients
q.s.
Approved Colour used
82
Disulfiram Tablets I.P 500mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Disulfiram
I.P.
500 mg
Excipients
q.s.
Approved colour used
83
Disulfiram Tablets I.P 250mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Disulfiram
I.P.
250 mg
Excipients
q.s.
Approved colour used
84
Ursodeoxycholic Acid SR Tablets 300mg
Composition
Standard
Quantity
Each film coated sustained release tablet contains :
Ursodeoxycholic Acid
I.P.
300 mg
Excipients
q.s.
Approved colour used
85
Etoricoxib and Thiocolchicoside Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Etoricoxib
I.P.
60 mg
Thiocolchicoside
I.P.
8 mg
Excipients
q.s.
86
Piracetam Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Piracetam
I.P.
800 mg
Excipients
q.s.
Approved Colour used
87
Rifaximin Tablets 550mg
Composition
Standard
Quantity
Each film coated tablet contains :
Rifaximin
I.P.
550 mg
Excipients
q.s.
Approved colour used
88
Rifaximin Tablets 400mg
Composition
Standard
Quantity
Each film coated tablet contains :
Rifaximin
I.P.
400 mg
Excipients
q.s.
Approved colour used
89
Rifaximin Tablets 200mg
Composition
Standard
Quantity
Each film coated tablet contains :
Rifaximin
I.P.
200 mg
Excipients
q.s.
Approved colour used
90
Telmisartan and Amlodipine Besilate Tablets I.P
Composition
Standard
Quantity
Each uncoated bilayered tablet contains :
Telmisartan
I.P.
40 mg
Amlodipine Besilate (eq. to Amlodipine)
I.P.
5 mg
Excipients
q.s.
91
Rifaximin Tabs 200mg
Each unc
Composition
Standard
Quantity
Each uncoated tablet contains :
Rifaximin
200 mg
Excipients
q.s.
Approved colour used
92
Rifaximin Tabs 400mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Rifaximin
400 mg
Excipients
q.s.
Approved colour used
93
Metronidazole & Furazolidone Bolus (only veterinary use)
Composition
Standard
Quantity
Each bolus contains :
Metronidazole
I.P.
1 g
Furazolidone
I.P.
200 mg
Excipients
q.s.
Approved colour used
94
Sulphadiazine & Trimethoprim Bolus I.P. (only veterinary use)
Composition
Standard
Quantity
Each bolus contains :
Sulphadiazine
I.P.
1000 mg
Trimethoprim
I.P.
200 mg
Excipients
q.s.
Approved colour used
95
Flunixin Meglumine & Serratiopeptidase Bolus (only veterinary use)
Composition
Standard
Quantity
Each uncoated bolus contains :
Flunixin Meglumine (eq. to Flunixin)
I.P.
1000 mg
Serratiopeptidase (eq. to enzyme activity 2,00,000 units, as enteric coated granules)
I.P.
100 mg
Excipients
q.s.
Approved Colour used
96
Oxfendazole Bolus (only veterinary use)
Composition
Standard
Quantity
Each uncoated bolus contains :
Oxfendazole
I.P.
2200 mg
Excipients
q.s.
Approved Colour used
97
Calcium Carbonate, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5 Phosphate Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Calcium Carbonate (Eq. to Elemental Calcium)
I.P.
500 mg
Vitamin D3
I.P.
2000 IU
Methylcobalamin
I.P.
1500 mcg
L-Methylfolate Calcium
1 mg
Pyridoxal-5 Phosphate
20 mg
Excipients
q.s.
Approved Colour used
98
Calcium, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5 Phosphate Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Calcium Carbonate (from an Organic source of Oyster Shell) Eq. to Elemental Calcium
I.P.
500 mg
Vitamin D3
I.P.
2000 IU
Methylcobalamin
I.P.
1500 mcg
L-Methylfolate Calcium
1 mg
Pyridoxal-5 Phosphate
0.5 mg
Excipients
q.s.
Approved Colour used
99
Clomipramine HCl Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Clomipramine Hydrochloride
I.P.
50 mg
Excipients
q.s.
Approved Colour used
100
Fluvoxamine Maleate Tablets I.P 100 mg.
Composition
Standard
Quantity
Each film coated tablet contains :
Fluvoxamine Maleate
I.P.
100 mg
Excipients
q.s.
Approved Colour used
101
Fluvoxamine Maleate Tablets I.P 50 mg.
Composition
Standard
Quantity
Each film coated tablet contains :
Fluvoxamine Maleate
I.P.
50 mg
Excipients
q.s.
Approved Colour used
102
Procyclidine HCl Tablets I.P 5mg.
Composition
Standard
Quantity
Each uncoated tablet contains :
Procyclidine Hydrochloride
I.P.
5 mg
Excipients
q.s.
Approved Colour used
103
Eperisone HCl Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Eperisone Hydrochloride
50 mg
Excipients
q.s.
Approved Colour used
104
Methylcobalamin, Alpha Lipoic Acid, Benfotiamine, Folic Acid, Chromium Polynicotinate, Inositol, Pyridoxine HCl, Vitamin D3 & Calcium Carbonate Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Methylcobalamin
I.P.
1500 mcg
Alpha Lipoic Acid
I.P.
100 mg
Benfotiamine
USP
150 mg
Folic Acid
I.P.
1.5 mg
Chromium Polynicotinate
200 mcg
Inositol
I.P.
100 mg
Pyridoxine Hydrochloride
I.P.
3 mg
Vitamin D3
I.P.
1000 IU
Calcium Carbonate
I.P.
500 mg
Excipients
q.s.
Approved Colour used
105
Dapagliflozin and Metformin HCl (ER) Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Dapagliflozin Propanediol Monohydrate (Eq. to Dapagliflozin)
10 mg
Metformin HCl (as extended release form)
I.P.
500 mg
Excipients
q.s.
Approved Colour used
106
Vildagliptin Tablets I.P 50 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Vildagliptin
I.P.
50 mg
Excipients
q.s.
Approved Colour used
107
Rosuvastatin and Fenofibrate Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Rosuvastatin Calcium (eq. to Rosuvastatin)
I.P.
10 mg
Fenofibrate
I.P.
145 mg
Excipients
q.s.
Approved Colour used
108
Bilastine and Montelukast Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Bilastine
I.P.
20 mg
Montelukast Sodium (Eq. to Montelukast)
10 mg
Excipients
q.s.
Approved Colour used
109
Duloxetine Gastro-resistant Tablets I.P. 30mg
Composition
Standard
Quantity
Each enteric coated tablet contains :
Duloxetine Hydrochloride (eq. to Duloxetine)
I.P.
30 mg
Excipients
q.s.
Approved Colour used
110
Duloxetine Gastro-resistant Tablets I.P. 20mg
Composition
Standard
Quantity
Each enteric coated tablet contains :
Duloxetine Hydrochloride (eq. to Duloxetine)
I.P.
20 mg
Excipients
q.s.
Approved Colour used
111
Naproxen Tablets I.P 500mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Naproxen
I.P.
500 mg
Excipients
q.s.
Approved Colour used
112
Propranolol Hydrochloride Tablets I.P 40mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Propranolol Hydrochloride
I.P.
40 mg
Excipients
q.s.
Approved Colour used
113
Tadalafil Tablets I.P 10mg
Composition
Standard
Quantity
Each film coated tablet contains :
Tadalafil
I.P.
10 mg
Excipients
q.s.
Approved Colour used
114
Drotaverine Hydrochloride Tablets I.P 40mg
Composition
Standard
Quantity
Each film coated tablet contains :
Drotaverine Hydrochloride
I.P.
40 mg
Excipients
q.s.
Approved Colour used
115
Gabapentin Tablets I.P 300 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Gabapentin
I.P.
300 mg
Excipients
q.s.
Approved Colour used
116
Gabapentin Tablets I.P 100 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Gabapentin
I.P.
100 mg
Excipients
q.s.
Approved Colour used
117
Rosuvastatin Calcium and Ezetimibe Tablets I.P.
Composition
Standard
Quantity
Each film coated tablet contains :
Rosuvastatin Calcium (eq. to Rosuvastatin)
I.P.
40 mg
Ezetimibe
I.P.
10 mg
Excipients
q.s.
Approved Colour used
118
Rosuvastatin Calcium and Ezetimibe Tablets I.P.
Composition
Standard
Quantity
Each film coated tablet contains :
Rosuvastatin Calcium (eq. to Rosuvastatin)
I.P.
20 mg
Ezetimibe
I.P.
10 mg
Excipients
q.s.
Approved Colour used
119
Amlodipine Besylate and Metoprolol Succinate (ER) Tablets
Composition
Standard
Quantity
Each uncoated bilayered tablet contains :
Amlodipine Besylate (Eq. to Amlodipine)
I.P.
5 mg
Metoprolol Succinate (Eq. to Metoprolol Tartrate, extended release)
I.P.
47.50 mg / 50 mg
Excipients
q.s.
Approved Colour used
120
Voglibose and Metformin Hydrochloride (SR) Tablets
Composition
Standard
Quantity
Each uncoated bilayered tablet contains :
Voglibose
I.P.
0.3 mg
Metformin Hydrochloride (sustained released)
I.P.
500 mg
Excipients
q.s.
Approved Colour used
121
Amitriptyline Hydrochloride Tablets I.P
Composition
Standard
Quantity
Each film coated tablet contains :
Amitriptyline Hydrochloride
I.P.
50 mg
Excipients
q.s.
Approved Colour used
122
Amitriptyline Hydrochloride Tablets I.P
Composition
Standard
Quantity
Each film coated tablet contains :
Amitriptyline Hydrochloride
I.P.
25 mg
Excipients
q.s.
Approved Colour used
123
Amitriptyline Hydrochloride Tablets I.P
Composition
Standard
Quantity
Each film coated tablet contains :
Amitriptyline Hydrochloride
I.P.
10 mg
Excipients
q.s.
Approved Colour used
124
Flavoxate Hydrochloride Tablets I.P 200mg
Composition
Standard
Quantity
Each film coated tablet contains :
Flavoxate Hydrochloride
I.P.
200 mg
Excipients
q.s.
Approved Colour used
125
Telmisartan 40 mg & Cilnidipine 10 mg Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Telmisartan
I.P.
40 mg
Cilnidipine
I.P.
10 mg
Excipients
q.s.
Approved Colour used
126
Ginkgo biloba Dry Extract Tablets I.P
Composition
Standard
Quantity
Each film coated tablet contains :
Ginkgo biloba dry extract (containing 9.6 mg of ginkgo flavone glycosides)
I.P.
40 mg
Excipients
q.s.
Approved colour used
127
L-Carnitine L-Tartrate, Methylcobalamin & Folic Acid Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
L-Carnitine L-Tartrate Eq. to L-Carnitine
500 mg
Methylcobalamin
I.P.
1500 mcg
Folic Acid
1.5 mg
Excipients
q.s.
Approved colour used
128
Methylcobalamin, L-Methyl Folate & Pyridoxal-5 Phosphate Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Methylcobalamin
I.P.
1500 mcg
L-5 Methyltetrahydrofolate Calcium (eq. to L-Methyl Folate)
1 mg
Pyridoxal-5 Phosphate
0.5 mg
Excipients
q.s.
Approved colour used
129
Esomeprazole Gastro-resistant Tablets I.P 40mg
Composition
Standard
Quantity
Each enteric coated tablet contains :
Esomeprazole Magnesium Trihydrate (eq. to Esomeprazole)
I.P.
40 mg
Excipients
q.s.
Approved colour used
130
Esomeprazole Gastro-resistant Tablets I.P 20mg
Composition
Standard
Quantity
Each enteric coated tablet contains :
Esomeprazole Magnesium Trihydrate (eq. to Esomeprazole)
I.P.
20 mg
Excipients
q.s.
Approved colour used
131
Citicoline and Piracetam Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Citicoline Sodium (eq. to Citicoline)
I.P.
500 mg
Piracetam
I.P.
800 mg
Excipients
q.s.
Approved Colour used
132
Ambroxol Hydrochloride, Levocetirizine Hydrochloride, Guaiphenesin and Menthol Syrup
Composition
Standard
Quantity
Each 5 ml contains:
Ambroxol Hydrochloride
I.P.
15 mg
Levocetirizine Hydrochloride
I.P.
2.5 mg
Guaiphenesin
I.P.
50 mg
Menthol
I.P.
1 mg
In a flavoured syrup base
q.s.
Excipients
q.s.
Colour
Approved colour used
133
Magaldrate and Simethicone Oral Suspension U.S.P.
Composition
Standard
Quantity
Each 5 ml contains:
Magaldrate (anhydrous)
I.P.
400 mg
Simethicone
I.P.
20 mg
Sorbitol Solution 70% (Non-crystallizing)
I.P.
q.s.
Purified Water
I.P.
q.s.
Excipients
q.s.
Approved Colour used
Dosage:
Adults & Children over 12 years: 1–2 teaspoonfuls between meals & at bedtime.
Children 5–12 years: Half of the above dose or as directed by the physician.
134
Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylepherine Hydrochloride Syrup
Composition
Standard
Quantity
Each 5 ml (one teaspoonful) contains :
Dextromethorphan Hydrobromide
I.P.
10 mg
Chlorpheniramine Maleate
I.P.
2 mg
Phenylephrine Hydrochloride
I.P.
5 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
Dosage:
Adults: 10 ml, 3–4 times a day
Children (2–6 years): 2.5 ml, 3–4 times a day
Children (6–12 years): 5 ml, 3–4 times a day
135
Rosuvastatin Calcium Tablets I.P. 40 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Rosuvastatin Calcium (eq. to Rosuvastatin)
I.P.
40 mg
Excipients
q.s.
Approved Colour used
136
Cyproheptadine Hydrochloride and Tricholine Citrate Syrup
Composition
Standard
Quantity
Each 5 ml contains :
Cyproheptadine Hydrochloride (anhydrous)
I.P.
2 mg
Tricholine Citrate (65%)
275 mg
Sorbitol Solution 70% (Non-crystallizing)
I.P.
q.s.
Excipients
q.s.
In a Flavoured Syrup base
q.s.
Approved Colour used
137
Terbutaline Sulphate, Ambroxol Hydrochloride, Guaiphenesin and Menthol Syrup
Composition
Standard
Quantity
Each 5 ml contains :
Terbutaline Sulphate
I.P.
2.5 mg
Ambroxol Hydrochloride
I.P.
30 mg
Guaiphenesin
I.P.
100 mg
Menthol
I.P.
2.5 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
138
Deflazacort Oral Suspension
Composition
Standard
Quantity
Each 5 ml contains :
Deflazacort
6 mg
In a flavoured syrup base
q.s.
Excipients
q.s.
Approved Colour used
139
Ambroxol Hydrochloride, Levosalbutamol Sulphate and Guaiphenesin Syrup
Composition
Standard
Quantity
Each 5 ml contains :
Ambroxol Hydrochloride
I.P.
30 mg
Levosalbutamol Sulphate eq. to Levosalbutamol
I.P.
1 mg
Guaiphenesin
I.P.
50 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved colour used
140
Paracetamol, Phenylephrine HCl, Chlorpheniramine Maleate, Sodium Citrate and Menthol syrup Tablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Paracetamol
I.P.
125 mg
Phenylephrine Hydrochloride
I.P.
5 mg
Chlorpheniramine Maleate
I.P.
0.5 mg
Sodium Citrate
I.P.
60 mg
Menthol
I.P.
1 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
141
Metformin Hydrochloride Sustained Released Tablets I.P.
Composition
Standard
Quantity
Each uncoated sustained release tablet contains :
Metformin Hydrochloride
I.P.
1000 mg
Excipients
q.s.
Approved Colour used
142
Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin and Menthol Syrup
Composition
Standard
Quantity (per 5 ml)
Each 5 ml contains :
Ambroxol Hydrochloride
I.P.
15 mg
Terbutaline Sulphate
I.P.
1.25 mg
Guaiphenesin
I.P.
50 mg
Menthol
I.P.
2.5 mg
Excipients
q.s.
In a flavoured syrup base
q.s.
Approved Colour used
143
Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylepherine Hydrochloride Tablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Dextromethorphan Hydrobromide
I.P.
10 mg
Chlorpheniramine Maleate
I.P.
2 mg
Phenylepherine Hydrochloride
I.P.
5 mg
Excipients
q.s.
Colour: Ponceau-4R
144
Lansoprazole Orally Disintegrating Tablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Lansoprazole (as enteric coated pellets)
I.P.
15 mg
Excipients
q.s.
Approved Colour used
145
Aceclofenac and Paracetamol Tablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Aceclofenac
I.P.
100 mg
Paracetamol
I.P.
325 mg
Excipients
q.s.
Approved Colour used
146
Fexofenadine and Montelukast Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Fexofenadine Hydrochloride
I.P.
120 mg
Montelukast Sodium (eq. to Montelukast)
I.P.
10 mg
Excipients
q.s.
Approved Colour used
147
Telmisartan 40 mg and Chlorthalidone 12.5 mg Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Telmisartan
I.P.
40 mg
Chlorthalidone
I.P.
12.5 mg
Excipients
q.s.
Approved Colour used
148
Silodosin 8mg & Dutasteride 0.5mg Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Silodosin
8 mg
Dutasteride (as uncoated tablet)
I.P.
0.5 mg
Excipients
q.s.
Approved colour used in empty capsule shells
149
Diacerein Capsules 50mg I.P
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Diacerein
I.P.
50 mg
Excipients
q.s.
Approved colour used in empty capsule shells
150
Telmisartan 80 mg and Chlorthalidone 12.5 mg Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Telmisartan
I.P.
80 mg
Chlorthalidone
I.P.
12.5 mg
Excipients
q.s.
Approved Colour used
151
Calcium Dobesilate Capsules 500 mg.
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Calcium Dobesilate Monohydrate
I.P.
500 mg
Excipients
q.s.
Approved colour used in empty capsule shells
152
Metoprolol Succinate (ER) Tablets I.P.
Composition
Standard
Quantity
Each uncoated extended release tablet contains :
Metoprolol Succinate (eq. to Metoprolol Tartrate, extended release)
I.P.
50 mg
(Metoprolol Succinate actual strength)
I.P.
47.50 mg
Excipients
q.s.
Approved Colour used
153
Alpha Lipoic Acid, Methylcobalamin, Pyridoxine Hydrochloride, Folic Acid, Benfotiamine, Chromium Picolinate & Biotin Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Alpha Lipoic Acid
USP
100 mg
Methylcobalamin
I.P.
1500 mcg
Pyridoxine Hydrochloride
I.P.
3 mg
Folic Acid
I.P.
1.5 mg
Benfotiamine
I.P.
50 mg
Chromium Picolinate eq. to Chromium
USP
200 mcg
Biotin
USP
5 mg
Excipients
q.s.
Approved colour used in empty capsule shells
154
Itraconazole Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Itraconazole (as pellets)
I.P.
100 mg
Excipients
q.s.
Approved colour used in empty capsule shells & pellets
155
Aspirin Gasto-resistant & Rosuvastatin Capsules I.P
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Aspirin (as enteric coated pellets)
I.P.
75 mg
Rosuvastatin Calcium eq. to Rosuvastatin (as pellets)
I.P.
20 mg
Excipients
q.s.
Approved Colour used in empty capsule shells & pellets
156
Metoprolol Succinate (ER) Tablets I.P.
Composition
Standard
Quantity
Each uncoated extended release tablet contains :
Metoprolol Succinate (eq. to Metoprolol Tartrate, extended release)
I.P.
25 mg
Excipients
q.s.
Approved Colour used
157
Diclofenac Potassium Paracetamol and Serratiopeptidase Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)
Composition
Standard
Quantity
Each film coated tablet contains :
Diclofenac Potassium
B.P.
50 mg
Paracetamol
I.P.
325 mg
Serratiopeptidase (as enteric coated granules, eq. to enzymatic activity 20,000 units)
I.P.
10 mg
Excipients
q.s.
Approved Colour used
158
Glimepiride, Metformin HCl (SR) and Pioglitazone Tablets [Note: Package Insert as per H&FW Deptt. Notification No. GSR520(E) dated 31.07.2013 to to be enclosed]
Composition
Standard
Quantity
Each uncoated bilayered tablet contains :
Glimepiride
I.P.
1 mg
Metformin Hydrochloride (In sustained release form)
I.P.
500 mg
Pioglitazone Hydrochloride eq. to Pioglitazone
I.P.
15 mg
Excipients
q.s.
Approved Colour used
159
Itraconazole Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Itraconazole (as pellets)
I.P.
200 mg
Excipients
q.s.
Approved Colour used in empty capsule shells
160
Mefenamic Acid Capsules I.P 250 mg
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Mefenamic Acid
I.P.
250 mg
Excipients
q.s.
Approved colour used in empty capsule shells
161
Glimepiride, Metformin HCl (SR) and Pioglitazone Tablets [Note: Package Insert as per H&FW Deptt. Notification No. GSR520(E) dated 31.07.2013 to to be enclosed]
Composition
Standard
Quantity
Each uncoated bilayered tablet contains :
Glimepiride
I.P.
2 mg
Metformin Hydrochloride (In sustained release form)
I.P.
500 mg
Pioglitazone Hydrochloride eq. to Pioglitazone
I.P.
15 mg
Excipients
q.s.
Approved Colour used
162
Diclofenac Potassium and Serratiopeptidase Tablets
Composition
Standard
Quantity
Each enteric coated tablet contains :
Diclofenac Potassium
B.P.
50 mg
Serratiopeptidase (as enteric coated granules eq. to enzymatic activity 20,000 units)
I.P.
10 mg
Excipients
q.s.
Approved Colour used
163
Thiocolchicoside Capsules I.P 8 mg
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Thiocolchicoside
I.P.
8 mg
Excipients
q.s.
Approved colour used in empty capsule shells
164
Thiocolchicoside Capsules I.P 4 mg
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Thiocolchicoside
I.P.
4 mg
Excipients
q.s.
Approved colour used in empty capsule shells
165
Rabeprazole and Ondansetron Tablets
Composition
Standard
Quantity
Each enteric coated tablet contains :
Rabeprazole Sodium
I.P.
20 mg
Ondansetron Hydrochloride(eq. to Ondansetron)
I.P.
4 mg
Excipients
q.s.
Approved Colour used
166
Doxylamine Succinate, Pyridoxine HCl & Folic Acid Tablets
Composition
Standard
Quantity
Each enteric coated tablet contains :
Doxylamine Succinate
USP
10 mg
Pyridoxine Hydrochloride
I.P.
10 mg
Folic Acid
I.P.
2.5 mg
Excipients
q.s.
Approved Colour used
167
Clindamycin Hydrochloride Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Clindamycin Hydrochloride eq. to Clindamycin
I.P.
300 mg
Excipients
q.s.
Approved colour used in empty capsule shells
168
Aceclofenac, Paracetamol, Cetirizine Dihydrochloride, Phenylephrine HCl and CaffeineTablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Aceclofenac
I.P.
100 mg
Paracetamol
I.P.
325 mg
Cetirizine Dihydrochloride
I.P.
10 mg
Phenylephrine Hydrochloride
I.P.
5 mg
Caffeine
I.P.
25 mg
Excipients
q.s.
Approved Colour used
169
Rosuvastatin and Aspirin Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Rosuvastatin Calcium eq. to Rosuvastatin (as pellets)
I.P.
10 mg
Aspirin (as enteric coated pellets)
I.P.
75 mg
Excipients
q.s.
Approved colour used
170
Ferrous Ascorbate, Folic acid and Zinc Sulphate Monohydrate Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Ferrous Ascorbate
I.P.
100 mg
Folic Acid
I.P.
1.5 mg
Zinc Sulphate Monohydrate (eq. to Elemental Zinc)
I.P.
22.5 mg
Excipients
q.s.
Approved Colour used
171
Rosuvastatin and Aspirin Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Rosuvastatin Calcium eq. to Rosuvastatin (as granules)
I.P.
20 mg
Aspirin (as enteric coated tablets)
I.P.
75 mg
Excipients
q.s.
Approved colour used
172
Rosuvastatin and Aspirin Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Rosuvastatin Calcium eq. to Rosuvastatin (as granules)
I.P.
10 mg
Aspirin (as enteric coated tablets)
I.P.
75 mg
Excipients
q.s.
Approved colour used
173
Acebrophylline Sustained Release, Fexofenadine HCl and Montelukast Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Acebrophylline (as sustained release form)
200 mg
Fexofenadine Hydrochloride
I.P.
120 mg
Montelukast Sodium (eq. to Montelukast)
I.P.
10 mg
Excipients
q.s.
Approved Colour used
174
Levocetirizine Dihydrochloride, Montelukast and Ambroxol HCl (SR) Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Levocetirizine Dihydrochloride
I.P.
5 mg
Montelukast Sodium (eq. to Montelukast)
I.P.
10 mg
Ambroxol Hydrochloride (as sustained release)
I.P.
75 mg
Excipients
q.s.
Approved Colour used
175
Naproxen and Domperidone Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Naproxen
I.P.
500 mg
Domperidone
I.P.
10 mg
Excipients
q.s.
Approved Colour used
176
Doxycycline & Lactic Acid Bacillus Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Doxycycline Hydrochloride eq. to Doxycycline
I.P.
100 mg
Lactic Acid Bacillus
60 Million Spores
Excipients
q.s.
Approved colour used in capsule shells
177
Rosuvastatin, Clopidogrel and Aspirin Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Rosuvastatin Calcium eq. to Rosuvastatin (as pellets)
I.P.
10 mg
Clopidogrel Bisulphate eq. to Clopidogrel (as pellets)
I.P.
75 mg
Aspirin (as enteric coated pellets)
I.P.
75 mg
Excipients
q.s.
Approved colour used
178
Rabeprazole Sodium(EC) and Aceclofenac (SR) Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Rabeprazole Sodium (as enteric coated pellets)
I.P.
20 mg
Aceclofenac (as sustained release pellets)
I.P.
200 mg
Excipients
q.s.
Approved colour used in empty capsule shells
179
Esomeprazole (EC) and Itopride HCl (SR) Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Esomeprazole Magnesium Trihydrate eq. to Esomeprazole (as enteric coated pellets)
I.P.
40 mg
Itopride Hydrochloride (as sustained released pellets)
I.P.
150 mg
Excipients
q.s.
Approved colour used in empty capsule shells
180
Omeprazole Gastro-resistant Capsules I.P.
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Omeprazole (as gastro resistant pellets)
I.P.
20 mg
Excipients
q.s.
Approved colour used in capsule shells
181
Teneligliptin and Metformin Hydrochloride (ER)Tablets
Composition
Standard
Quantity
Each uncoated bilayered tablet contains :
Teneligliptin Hydrobromide Hydrate (eq. to Teneligliptin)
I.P.
20 mg
Metformin Hydrochloride (as extended release)
I.P.
500 mg
Excipients
q.s.
Approved Colour used
182
Methylcobalamin, Alpha Lipoic Acid, Benfotiamine, Pyridoxine HCl, Inositol and Folic Acid Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Methylcobalamin
I.P.
1000 mcg
Alpha Lipoic Acid
I.P.
200 mg
Benfotiamine
100 mg
Folic Acid
I.P.
1.5 mg
Pyridoxine HCl
I.P.
3 mg
Inositol
USP
100 mg
Excipients
q.s.
Approved colour used in empty capsule shells
183
Methylcobalamin, Alpha Lipoic Acid, Benfotiamine, Pyridoxine HCl, Inositol and Folic Acid Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Methylcobalamin
I.P.
1000 mcg
Alpha Lipoic Acid
I.P.
200 mg
Benfotiamine
100 mg
Folic Acid
I.P.
1.5 mg
Pyridoxine HCl
I.P.
3 mg
Inositol
USP
100 mg
Excipients
q.s.
Approved colour used in empty capsule shells
184
Methylcobalamin, Alpha Lipoic Acid, Thiamine Mononitrate, Pyridoxine Hydrochloride, and Folic Acid Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Methylcobalamin
I.P.
1500 mcg
Alpha Lipoic Acid
I.P.
100 mg
Thiamine Mononitrate
I.P.
10 mg
Pyridoxine Hydrochloride
I.P.
3 mg
Folic Acid
I.P.
1.5 mg
Excipients
q.s.
Appropriate overages of vitamins are added to compensate loss on storage
Approved colour used in empty capsule shells
185
Paracetamol, Phenylephrine HCl and Cetirizine HCl Tablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Paracetamol
I.P.
325 mg
Phenylephrine Hydrochloride
I.P.
5 mg
Cetirizine Hydrochloride
I.P.
5 mg
Excipients
q.s.
Approved Colour used
186
Pregabalin and Methylcobalamin Capsules I.P
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Pregabalin
I.P.
75 mg
Methylcobalamin
I.P.
750 mcg
Excipients
q.s.
Approved colour used in empty capsule shells
Appropriate overages of vitamin added to compensate loss on storage
187
Flupentixol and Melitracen Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Flupentixol Hydrochloride (Eq. to Flupentixol)
B.P.
0.5 mg
Melitracen Hydrochloride (Eq. to Melitracen)
10 mg
Excipients
q.s.
Approved Colour used
188
Esomeprazole and Levosulpride Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Esomeprazole Magnesium Trihydrate eq. to Esomeprazole (as enteric coated pellets)
I.P.
40 mg
Levosulpiride (as sustained released pellets)
75 mg
Excipients
q.s.
Approved colour used in empty capsule shells
189
Sitagliptin Phosphate and Metformin Hydrochloride Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Sitagliptin Phosphate Monohydrate (Eq. to Sitagliptin)
I.P.
50 mg
Metformin Hydrochloride
I.P.
500 mg
Excipients
q.s.
Approved Colour used
190
Pantoprazole and Levosulpiride Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Pantoprazole Sodium eq. to Pantoprazole (as enteric coated pellets)
I.P.
40
Levosulpiride (as sustained released pellets)
75
Excipients
Approved colour used in empty capsule shells
191
Fexofenadine and Montelukast Chewable Tablets
Composition
Standard
Quantity
Each uncoated chewable tablet contains :
Fexofenadine Hydrochloride
I.P.
120 mg
Montelukast Sodium (eq. to Montelukast)
I.P.
10 mg
Excipients
q.s.
Approved Colour used
192
Levetiracetam Tablets I.P
Composition
Standard
Quantity
Each film coated tablet contains :
Levetiracetam
I.P.
500 mg
Excipients
q.s.
Approved Colour used
193
Rebeprazole and Itopride Hydrochloride Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Rabeprazole Sodium (as enteric coated pellets)
I.P.
20 mg
Itopride Hydrochloride (as sustained released pellets)
150 mg
Excipients
q.s.
Approved colour used in empty capsule shells
194
Esomeprazole and Domperidone Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Esomeprazole Magnesium Trihydrate eq. to Esomeprazole (as enteric coated pellets)
I.P.
40 mg
Domperidone (as sustained released pellets)
I.P.
30 mg
Excipients
q.s.
Approved colour used in empty capsule shells
195
Tamsulosin HCl (MR) and Dutasteride Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Tamsulosin Hydrochloride (as modified release)
I.P.
0.4 mg
Dutasteride
I.P.
0.5 mg
Excipients
q.s.
Approved Colour used
196
Rabeprazole and Levosulpride Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Rabeprazole Sodium (as enteric coated pellets)
I.P.
20 mg
Levosulpiride (as sustained released pellets)
75 mg
Excipients
q.s.
Approved colour used in empty capsule shells
197
Pantoprazole Gasto-resistant and Domperidone Prolonged-release Capsules I.P
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Pantoprazole Sodium eq. to Pantoprazole (as gastro-resistant pellets)
I.P.
40 mg
Domperidone (as prolonged-release pellets)
I.P.
30 mg
Excipients
q.s.
Approved colour used in empty capsule shells
198
Rabeprazole and Domperidone Capsule
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Rabeprazole Sodium (as enteric coated pellets)
I.P.
20 mg
Domperidone (as sustained released pellets)
I.P.
30 mg
Excipients
q.s.
Approved colour used in empty capsule shells
199
Omeprazole and Domperidone Capsules I.P
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Omeprazole (as enteric coated pellets)
I.P.
20 mg
Domperidone
I.P.
10 mg
Excipients
q.s.
Approved colour used in empty capsule shells
200
Methylcobalamin, Alpha Lipoic Acid, Inositol, Folic Acid, Chromium Polynicotinate, Selenium Dioxide and Benfotiamine Capsules
Composition
Standard
Quantity
Each hard gelatin capsule contains :
Methylcobalamin
I.P.
1500 mcg
Alpha Lipoic Acid
USP
100 mg
Inositol
USP
100 mg
Folic Acid
I.P.
1.5 mg
Chromium Polynicotinate
USP
200 mcg
Selenium Dioxide
B.P.
55 mcg
Benfotiamine
USP
150 mg
Excipients
q.s.
Approved colour used in empty capsule shells
201
Vildagliptin and Metformin Hydrochloride Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Vildagliptin
I.P.
50 mg
Metformin Hydrochloride
I.P.
1000 mg
Excipients
q.s.
Approved Colour used
202
Vildagliptin and Metformin Hydrochloride Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Vildagliptin
I.P.
50 mg
Metformin Hydrochloride
I.P.
850 mg
Excipients
q.s.
Approved Colour used
203
Vildagliptin and Metformin Hydrochloride Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Vildagliptin
I.P.
50 mg
Metformin Hydrochloride
I.P.
500 mg
Excipients
q.s.
Approved Colour used
204
Metformin HCl Prolonged release and Glimepiride Tablets I.P
Composition
Standard
Quantity
Each uncoated bilayered tablet contains :
Metformin Hydrochloride (In Prolonged release form)
I.P.
500 mg
Glimepiride
I.P.
2 mg
Excipients
q.s.
Approved Colour used
205
Metformin HCl Prolonged release and Glimepiride Tablets I.P
Composition
Standard
Quantity
Each uncoated bilayered tablet contains :
Metformin Hydrochloride (In Prolonged release form)
I.P.
500 mg
Glimepiride
I.P.
1 mg
Excipients
q.s.
Approved Colour used
206
Citicoline and Piracetam Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Citicoline Sodium (eq. to Citicoline)
I.P.
500 mg
Piracetam
I.P.
400 mg
Excipients
q.s.
Approved Colour used
207
Drotaverine Hydrochloride and Mefenamic Acid Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Drotaverine Hydrochloride
I.P.
80 mg
Mefenamic Acid
I.P.
250 mg
Excipients
q.s.
Approved Colour used
208
Trypsin,Bromelain, Rustoside Trihydrate and Aceclofenac Tablets
Composition
Standard
Quantity
Each enteric coated tablet contains :
Trypsin
B.P.
48 mg
Bromelain
90 mg
Rustoside Trihydrate
B.P.
100 mg
Aceclofenac
I.P.
100 mg
Excipients
q.s.
Approved Colour used
209
Glimepiride and Metformin Hydrochloride (SR) Tablets
Composition
Standard
Quantity
Each uncoated bilayered tablet contains :
Glimepiride
I.P.
2 mg
Metformin Hydrochloride (sustained released)
I.P.
1000 mg
Excipients
q.s.
Approved Colour used
210
Diclofenac Potassium Paracetamol and Chlorzoxazone Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)
Composition
Standard
Quantity
Each film coated tablet contains :
Diclofenac Potassium
B.P.
50 mg
Paracetamol
I.P.
325 mg
Chlorzoxazone
USP
250 mg
Excipients
q.s.
Approved Colour used
211
Gabapentin & Nortriptyline HCl Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Gabapentin
I.P.
400 mg
Nortriptyline Hydrochloride (Eq. to Nortriptyline)
I.P.
10 mg
Excipients
q.s.
Approved Colour used
212
Ketorolac Tromethamine Dispersible Tablets 10mg
Composition
Standard
Quantity
Each uncoated dispersible tablet contains :
Ketorolac Tromethamine
I.P.
10 mg
Excipients
q.s.
Approved Colour used
213
Rabeprazole and Domperidone Tablets
Composition
Standard
Quantity
Each enteric coated tablet contains :
Rabeprazole Sodium
I.P.
20 mg
Domperidone
I.P.
10 mg
Excipients
q.s.
Approved Colour used
214
Amisulpiride Tablets IP 50 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Amisulpride
I.P.
50 mg
Excipients
q.s.
Approved colour used
215
Sildenafil Citrate Tablets I.P. 50 mg
Composition
Standard
Quantity
Each film-coated tablet contains :
Sildenafil Citrate (eq. to Sildenafil)
I.P.
50 mg
Excipients
q.s.
Approved Colour used
216
Tolperisone HCl and Diclofenac Sodium Tablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Tolperisone Hydrochloride
150 mg
Diclofenac Sodium
I.P.
50 mg
Excipients
q.s.
Approved Colour used
217
Cinnarizine and Domperidone Tablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Cinnarizine
I.P.
20 mg
Domperidone
I.P.
15 mg
Excipients
q.s.
Approved Colour used
218
Eperisone Hydrochloride and Paracetamol Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Eperisone Hydrochloride
50 mg
Paracetamol
I.P.
325 mg
Excipients
q.s.
Approved Colour used
219
Levosulpride Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Levosulpiride
50 mg
Excipients
q.s.
Approved Colour used
220
Terbinafine Tablets I.P 250 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Terbinafine Hydrochloride (eq. to Terbinafine)
I.P.
250 mg
Excipients
q.s.
Approved Colour used
221
Trypsin,Bromelain, Rustoside Trihydrate and Diclofenac Sodium Tablets
Composition
Standard
Quantity
Each enteric coated tablet contains :
Trypsin
B.P.
48 mg
Bromelain
90 mg
Rutoside Trihydrate
B.P.
100 mg
Diclofenac Sodium
I.P.
50 mg
Excipients
q.s.
Approved Colour used
222
Trypsin,Bromelain and Rustoside Trihydrate Tablets
Composition
Standard
Quantity
Each enteric coated tablet contains :
Trypsin
B.P.
48 mg
Bromelain
90 mg
Rutoside Trihydrate
B.P.
100 mg
Excipients
q.s.
Approved Colour used
223
Aceclofenac and Thiocolchicoside Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Aceclofenac
I.P.
100 mg
Thiocolchicoside
I.P.
8 mg
Excipients
q.s.
Approved Colour used
224
Levocetirizine Hydrochloride and Ambroxol Hydrochloride (SR) Tablets
Composition
Standard
Quantity
Each uncoated sustained released tablet contains :
Levocetirizine Hydrochloride
I.P.
5 mg
Ambroxol Hydrochloride (as sustained released)
I.P.
75 mg
Excipients
q.s.
Approved Colour used
225
Tranexamic Acid and Mefenamic Acid Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Tranexamic Acid
I.P.
500 mg
Mefenamic Acid
I.P.
250 mg
Excipients
q.s.
Approved Colour used
226
Etoricoxib and Paracetamol Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Etoricoxib
I.P.
60 mg
Paracetamol
I.P.
325 mg
Excipients
q.s.
Approved Colour used
227
Diclofenac Sodium and Serratiopeptidase Tablets
Composition
Standard
Quantity
Each enteric coated tablet contains :
Diclofenac Sodium
B.P.
50 mg
Serratiopeptidase (as enteric coated granules, eq. to enzymatic activity 20,000 units)
I.P.
10 mg
Excipients
q.s.
Approved Colour used
228
Glucosamine, Methylsulphonylmethane and Diacerein Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Glucosamine Sulphate Potassium Chloride (eq. to Glucosamine)
USP
446 mg (750 mg eq.)
Methylsulphonylmethane
USP
250 mg
Diacerein
I.P.
50 mg
Excipients
q.s.
Approved Colour used
229
Montelukast and Levocetirizine Hydrochloride Tablets I.P
Composition
Standard
Quantity
Each film coated tablet contains :
Levocetirizine Hydrochloride
I.P.
2.5 mg
Montelukast Sodium (eq. to Montelukast)
I.P.
4 mg
Excipients
q.s.
Approved Colour used
230
Aceclofenac Sustained Released Tablets 200mg
Composition
Standard
Quantity
Each uncoated sustained released tablet contains :
Aceclofenac
I.P.
200 mg
Excipients
q.s.
Approved Colour used
231
Lornoxicam and Paracetamol Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Lornoxicam
8 mg
Paracetamol
I.P.
325 mg
Excipients
q.s.
Approved Colour used
232
Lornoxicam and Paracetamol Tablets
Composition
Standard
Quantity
Each film coated tablet contains :
Lornoxicam
4 mg
Paracetamol
I.P.
325 mg
Excipients
q.s.
Approved Colour used
233
Metoprolol Succinate (ER) Tablets I.P.
Composition
Standard
Quantity
Each film coated tablet contains :
Metoprolol Succinate (eq. to Metoprolol Tartrate, extended released)
I.P.
47.50 mg (50 mg eq.)
Excipients
q.s.
Approved Colour used
234
Metoprolol Succinate (ER) Tablets I.P.
Composition
Standard
Quantity
Each film coated tablet contains :
Metoprolol Succinate (eq. to Metoprolol Tartrate, extended released)
I.P.
23.75 mg (25 mg eq.)
Excipients
q.s.
Approved Colour used
235
Mefenamic Acid and Dicyclomine HCl Tablets I.P
Composition
Standard
Quantity
Each uncoated tablet contains :
Mefenamic Acid
I.P.
250 mg
Dicyclomine Hydrochloride
I.P.
10 mg
Excipients
q.s.
Approved Colour used
236
Diclofenac Sodium and Paracetamol Tablets I.P (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)
Composition
Standard
Quantity
Each uncoated tablet contains :
Diclofenac Sodium
I.P.
50 mg
Paracetamol
I.P.
325 mg
Excipients
q.s.
237
Amlodipine Besylate and Metoprolol Succinate (ER)Tablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Amlodipine Besylate (Eq. to Amlodipine)
I.P.
5 mg
Metoprolol Succinate (eq. to Metoprolol Tartrate, Extended Released)
I.P.
47.5 mg (50 mg eq.)
Excipients
q.s.
Approved Colour used
238
Amlodipine Besilate and Atenolol Tablets I.P.
Composition
Standard
Quantity
Each uncoated tablet contains :
Amlodipine Besilate (eq. to Amlodipine)
I.P.
5 mg
Atenolol
I.P.
50 mg
Excipients
q.s.
Approved Colour used
239
Amlodipine Besilate Tablets I.P.
Composition
Standard
Quantity
Each film coated tablet contains :
Amlodipine Besilate (eq. to Amlodipine)
I.P.
5 mg
Excipients
q.s.
Approved Colour used
240
Metformin Hydrochloride Sustained Released Tablets I.P.
Composition
Standard
Quantity
Each uncoated tablet contains :
Metformin Hydrochloride (sustained released)
I.P.
500 mg
Excipients
q.s.
Approved Colour used
241
Losartan Potassium and Hydrochlorothiazide Tablets I.P.
Composition
Standard
Quantity
Each film coated tablet contains :
Losartan Potassium
I.P.
50 mg
Hydrochlorothiazide
I.P.
12.5 mg
Excipients
q.s.
Approved Colour used
242
Losartan Potassium and Amlodipine Tablets I.P.
Composition
Standard
Quantity
Each film coated tablet contains :
Losartan Potassium
I.P.
50 mg
Excipients
q.s.
Approved Colour used
243
Losartan Potassium Tablets I.P. 50 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Losartan Potassium
I.P.
50 mg
Excipients
q.s.
Approved Colour used
244
Linezolid Tablets I.P.
Composition
Standard
Quantity
Each film coated tablet contains :
Linezolid
I.P.
600 mg
Excipients
q.s.
Approved Colour used
245
Olmesartan Medoxomil and Amlodipine Tablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Olmesartan Medoxomil
I.P.
40 mg
Amlodipine Besylate (eq. to Amlodipine)
I.P.
5 mg
Excipients
q.s.
Approved Colour used
246
Olmesartan Medoxomil 20 mg and Hydrochlorothiazide 12.5 mg Tablets I.P
Composition
Standard
Quantity
Each uncoated tablet contains :
Olmesartan Medoxomil
I.P.
20 mg
Hydrochlorothiazide
I.P.
12.5 mg
Excipients
q.s.
Approved Colour used
247
Olmesartan Medoxomil Tablets I.P. 40 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Olmesartan Medoxomil
I.P.
40 mg
Excipients
q.s.
Approved Colour used
248
Olmesartan Medoxomil Tablets I.P. 20 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Olmesartan Medoxomil
I.P.
20 mg
Excipients
q.s.
Approved Colour used
249
Loratadine Tablets I.P.
Composition
Standard
Quantity
Each uncoated tablet contains :
Loratadine
I.P.
10 mg
Excipients
q.s.
Approved Colour used
250
Citicoline Tablets I.P 500 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Citicoline Sodium (eq. to Citicoline)
I.P.
500 mg
Excipients
q.s.
Approved Colour used
251
Hydroxyzine Tablets I.P. 25 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Hydroxyzine Hydrochloride
I.P.
25 mg
Excipients
q.s.
Approved Colour used
252
Hydroxyzine Tablets I.P. 10 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Hydroxyzine Hydrochloride
I.P.
10 mg
Excipients
q.s.
Approved Colour used
253
Voglibose Tablets I.P. 0.3 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Voglibose
I.P.
0.3 mg
Excipients
q.s.
Approved Colour used
254
Voglibose Tablets I.P. 0.2 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Voglibose
I.P.
0.2 mg
Excipients
q.s.
Approved Colour used
255
Febuxostat Tablets 80 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Febuxostat
80 mg
Excipients
q.s.
Approved Colour used
256
Febuxostat Tablets 40 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Febuxostat
40 mg
Excipients
q.s.
Approved Colour used
257
Serratiopeptidase Tablets I.P. 10 mg
Composition
Standard
Quantity
Each enteric coated tablet contains :
Serratiopeptidase (as enteric coated granules eq. to enzymatic activity 20,000 units)
I.P.
10 mg
Excipients
q.s.
Approved Colour used
258
Paracetamol Tablets I.P. 650 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Paracetamol
I.P.
650 mg
Excipients
q.s.
Approved Colour used
259
Betahistine Hydrochloride Tablets I.P.
Composition
Standard
Quantity
Each film coated tablet contains :
Betahistine Hydrochloride
I.P.
8 mg
Excipients
q.s.
Approved Colour used
260
Betahistine Hydrochloride Tablets I.P.
Composition
Standard
Quantity
Each film coated tablet contains :
Betahistine Hydrochloride
I.P.
16 mg
Excipients
q.s.
Approved Colour used
261
Levocetirizine Tablets I.P. 5 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Levocetirizine Hydrochloride
I.P.
5 mg
Excipients
q.s.
Approved Colour used
262
Cetirizine Hydrochloride Tablets I.P. 10 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Cetirizine Hydrochloride
I.P.
10 mg
Excipients
q.s.
Approved Colour used
263
Pantoprazole Gastro-resistant Tablets I.P. 40 mg
Composition
Standard
Quantity
Each enteric-coated tablet contains :
Pantoprazole Sodium eq. to Pantoprazole
I.P.
40 mg
Excipients
q.s.
Approved Colour used
264
Divalproex Extended Release Tablets I.P 1000mg
Composition
Standard
Quantity
Each film-coated extended-release tablet contains :
Divalproex Sodium eq. to Valproic Acid
I.P.
1000 mg
Excipients
q.s.
Approved Colour used
265
Divalproex Extended Release Tablets I.P 500mg
Composition
Standard
Quantity
Each film-coated extended-release tablet contains :
Divalproex Sodium eq. to Valproic Acid
I.P.
500 mg
Excipients
q.s.
Approved Colour used
266
Divalproex Extended Release Tablets I.P 250mg
Composition
Standard
Quantity
Each film-coated extended-release tablet contains :
Divalproex Sodium eq. to Valproic Acid
I.P.
250 mg
Excipients
q.s.
Approved Colour used
267
Telmisartan, Amlodipine and Hydrochlorothiazide Tablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Telmisartan
I.P.
40 mg
Amlodipine Besylate eq. to Amlodipine
I.P.
5 mg
Hydrochlorothiazide
I.P.
12.5 mg
Excipients
q.s.
Approved Colour used
268
Telmisartan 80 mg and Hydrochlorothiazide 12.5 mg Tablets I.P
Composition
Standard
Quantity
Each film-coated tablet contains :
Telmisartan
I.P.
80 mg
Hydrochlorothiazide
I.P.
12.5 mg
Excipients
q.s.
Approved Colour used
269
Telmisartan 40 mg and Hydrochlorothiazide 12.5 mg Tablets I.P.
Composition
Standard
Quantity
Each film-coated tablet contains :
Telmisartan
I.P.
40 mg
Hydrochlorothiazide
I.P.
12.5 mg
Excipients
q.s.
Approved Colour used
270
Telmisartan Tablets I.P. 80 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Telmisartan
I.P.
80 mg
Excipients
q.s.
Approved Colour used
271
Telmisartan Tablets I.P. 40 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Telmisartan
I.P.
40 mg
Excipients
q.s.
Approved Colour used
272
Telmisartan Tablets I.P. 20 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Telmisartan
I.P.
20 mg
Excipients
q.s.
Approved Colour used
273
Duloxetine Hydrochloride Tablets 30 mg
Composition
Standard
Quantity
Each enteric-coated tablet contains :
Duloxetine Hydrochloride eq. to Duloxetine
I.P.
30 mg
Excipients
q.s.
Approved Colour used
274
Duloxetine Hydrochloride Tablets 20mg
Composition
Standard
Quantity
Each enteric-coated tablet contains :
Duloxetine Hydrochloride eq. to Duloxetine
I.P.
20 mg
Excipients
q.s.
Approved Colour used
275
Rosuvastatin Calcium and Fenofibrate Tablets
Composition
Standard
Quantity
Each film-coated tablet contains :
Rosuvastatin Calcium eq. to Rosuvastatin
I.P.
10 mg
Fenofibrate
I.P.
160 mg
Excipients
q.s.
Colour
276
Rosuvastatin Calcium Tablets I.P. 20 mg
Composition
Standard
Quantity
Each film-coated tablet contains :
Rosuvastatin Calcium eq. to Rosuvastatin
I.P.
20 mg
Excipients
q.s.
Approved Colour used
277
Rosuvastatin Calcium Tablets I.P. 10 mg
Composition
Standard
Quantity
Each film-coated tablet contains :
Rosuvastatin Calcium eq. to Rosuvastatin
I.P.
10 mg
Excipients
q.s.
Approved Colour used
278
Rosuvastatin Calcium Tablets I.P. 5 mg
Composition
Standard
Quantity
Each film-coated tablet contains :
Rosuvastatin Calcium eq. to Rosuvastatin
I.P.
5 mg
Excipients
q.s.
Approved Colour used
279
Methylprednisolone Tablets I.P. 16 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Methylprednisolone
I.P.
16 mg
Excipients
q.s.
Approved Colour used
280
Methylprednisolone Tablets 8 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Methylprednisolone
I.P.
8 mg
Excipients
q.s.
Approved Colour used
281
Methylprednisolone Tablets I.P. 4 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Methylprednisolone
I.P.
4 mg
Excipients
q.s.
Approved Colour used
282
Atenolol Tablets I.P. 100 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Atenolol
I.P.
100 mg
Excipients
q.s.
Approved Colour used
283
Atenolol Tablets I.P. 50 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Atenolol
I.P.
50 mg
Excipients
q.s.
Approved Colour used
284
Atorvastatin Calcium and Fenofibrate Tablets
Composition
Standard
Quantity
Each film-coated tablet contains :
Atorvastatin Calcium eq. to Atorvastatin
I.P.
10 mg
Fenofibrate
I.P.
160 mg
Excipients
q.s.
Approved Colour used
285
Atorvastatin Tablets I.P. 40 mg
Composition
Standard
Quantity
Each film-coated tablet contains :
Atorvastatin Calcium eq. to Atorvastatin
I.P.
40 mg
Excipients
q.s.
Approved Colour used
286
Atorvastatin Tablets I.P. 20 mg
Composition
Standard
Quantity
Each film-coated tablet contains :
Atorvastatin Calcium eq. to Atorvastatin
I.P.
20 mg
Excipients
q.s.
Approved Colour used
287
Atorvastatin Tablets I.P. 10 mg
Composition
Standard
Quantity
Each film-coated tablet contains :
Atorvastatin Calcium eq. to Atorvastatin
I.P.
10 mg
Excipients
q.s.
Approved Colour used
288
Fexofenadine and Montelukast Tablets
Composition
Standard
Quantity
Each chewable film-coated tablet contains :
Fexofenadine Hydrochloride
I.P.
120 mg
Montelukast Sodium eq. to Montelukast
I.P.
10 mg
Excipients
q.s.
Approved Colour used
289
Fexofenadine Hydrochloride Tablets I.P. 180 mg
Composition
Standard
Quantity
Each film-coated tablet contains :
Fexofenadine Hydrochloride
I.P.
180 mg
Excipients
q.s.
Approved Colour used
290
Fexofenadine Hydrochloride Tablets I.P. 120 mg
Composition
Standard
Quantity
Each film-coated tablet contains :
Fexofenadine Hydrochloride
I.P.
120 mg
Excipients
q.s.
Approved Colour used
291
Escitalopram Tablets I.P 20 mg
Composition
Standard
Quantity
Each film-coated tablet contains :
Escitalopram Oxalate eq. to Escitalopram
I.P.
20 mg
Excipients
q.s.
Approved Colour used
292
Escitalopram Tablets I.P 10 mg
Composition
Standard
Quantity
Each film-coated tablet contains :
Escitalopram Oxalate eq. to Escitalopram
I.P.
10 mg
Excipients
q.s.
Approved Colour used
293
Escitalopram Tablets I.P 5 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Escitalopram Oxalate (eq. to Escitalopram)
I.P.
5 mg
Excipients
—
q.s.
Approved Colour used
—
—
294
Etoricoxib Tablets I.P 120 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Etoricoxib
I.P.
120 mg
Excipients
—
q.s.
Approved Colour used
—
—
295
Etoricoxib Tablets I.P 90 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Etoricoxib
I.P.
90 mg
Excipients
—
q.s.
Approved Colour used
—
—
296
Etoricoxib Tablets I.P 60 mg
Composition
Standard
Quantity
Each film-coated tablet contains :
Etoricoxib
I.P.
60 mg
Excipients
—
q.s.
Approved Colour used
—
—
297
Ondansetron Orally Disintegrating Tablets I.P. 8 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Ondansetron Hydrochloride (eq. to Ondansetron)
I.P.
8 mg
Excipients
—
q.s.
Approved Colour used
—
—
298
Ondansetron Orally Disintegrating Tablets I.P. 4 mg
Composition
Standard
Quantity
Each uncoated tablet contains :
Ondansetron Hydrochloride (eq. to Ondansetron)
I.P.
4 mg
Excipients
—
q.s.
Approved Colour used
—
—
299
Sildenafil Citrate Tablets I.P. 100 mg
Composition
Standard
Quantity
Each film-coated tablet contains :
Sildenafil Citrate (eq. to Sildenafil)
I.P.
100 mg
Excipients
—
q.s.
Approved Colour used
—
—
300
Paracetamol and Nimesulide Tablets (Not to be used for children below 12 years of age)
Composition
Standard
Quantity
Each uncoated tablet contains :
Paracetamol
I.P.
325 mg
Nimesulide
B.P.
100 mg
Excipients
—
q.s.
Approved Colour used
—
—
301
Roxithromycin Tablets I.P. 150 mg
Composition
Standard
Quantity
Each film coated tablet contains :
Roxithromycin
I.P.
150 mg
Excipients
—
q.s.
Approved Colour used
—
—
302
Deflazacort Tablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Deflazacort
—
30 mg
Excipients
—
q.s.
Approved Colour used
—
—
303
Deflazacort Tablets
Composition
Standard
Quantity
Each uncoated tablet contains :
Deflazacort
—
6 mg
Excipients
—
q.s.
Approved Colour used
—
—
304
Rabeprazole Gastro-resistant Tablets I.P. 20mg
Composition
Standard
Quantity
Each enteric coated tablet contains :
Rabeprazole Sodium
I.P.
20 mg
Excipients
—
q.s.
Approved Colour used
—
—
305
Ofloxacin & Ornidazole Tablets I.P
Composition
Standard
Quantity
Each film coated tablet contains :
Ofloxacin
I.P.
200 mg
Ornidazole
I.P.
500 mg
Excipients
—
q.s.
Approved Colour used
—
—
306
Levofloxacin Tablets I.P. 750 mg
Composition
Standard
Quantity
Each film coated tablet contains:
Levofloxacin Hemihydrate (eq. to Levofloxacin)
I.P.
750 mg
Excipients
—
q.s.
Approved Colour used
—
—
307
Levofloxacin Tablets I.P. 500 mg
Composition
Standard
Quantity
Each film coated tablet contains:
Levofloxacin Hemihydrate (eq. to Levofloxacin)
I.P.
500 mg
Excipients
—
q.s.
Approved Colour used
—
—
308
Levofloxacin Tablets I.P. 250 mg
Composition
Standard
Quantity
Each film coated tablet contains:
Levofloxacin Hemihydrate (eq. to Levofloxacin)
I.P.
250 mg
Excipients
—
q.s.
Approved Colour used
—
—
309
Pregabalin, Nortriptyline & Mecobalamin Tablets
Composition
Standard
Quantity
Each film coated tablet contains:
Pregabalin
I.P.
75 mg
Nortriptyline Hydrochloride (Eq. to Nortriptyline)
I.P.
10 mg
Mecobalamin
I.P.
1500 mcg
Excipients
—
q.s.
Approved Colour used
—
—
310
Azithromycin & Lactic Acid Bacillus Tablets
Composition
Standard
Quantity
Each film coated tablet contains:
Azithromycin Dihydrate (eq. to Azithromycin anhydrous)
I.P.
500 mg
Lactic Acid Bacillus
—
60 Million Spores
Excipients
—
q.s.
Approved Colour used
—
—
311
Ferrous Ascorbate, Cyanocobalamin, Folic Acid, Zinc Sulphate Monohydrate Tablets
Composition
Standard
Quantity
Each film coated tablet contains:
Ferrous Ascorbate
—
100 mg
Cyanocobalamin
I.P.
15 mcg
Folic Acid
I.P.
1.5 mg
Zinc Sulphate Monohydrate (eq. to Elemental Zinc)
I.P.
22.5 mg
Excipients
—
q.s.
Approved Colour used
—
—
312
Ofloxacin Tablets I.P.
Composition
Standard
Quantity
Each film coated tablet contains:
Ofloxacin
I.P.
200 mg
Excipients
—
q.s.
Approved Colour used
—
—
313
Pregabalin (SR) and Methylcobalamin Tablets
Composition
Standard
Quantity
Each uncoated tablet contains:
Pregabalin (Sustained Release)
I.P.
75 mg
Methylcobalamin
I.P.
1500 mcg
Excipients
—
q.s.
Approved Colour used
—
—
314
Calcium Citrate, Zinc,Vitamin D3 and Magnesium Tablets
Composition
Standard
Quantity
Each uncoated tablet contains:
Calcium Citrate
USP
1000 mg
Zinc Sulphate Monohydrate eq. to Elemental Zinc
I.P.
4 mg
Vitamin D3
I.P.
200 IU
Magnesium Hydroxide eq. to Elemental Magnesium
I.P.
100 mg
Excipients
—
q.s.
Approved Colour used
—
—
315
Gabapentin and Methylcobalamin Tablets
Composition
Standard
Quantity
Each film coated tablet contains:
Gabapentin
I.P.
300 mg
Methylcobalamin
I.P.
500 mcg
Excipients
—
q.s.
Approved Colour used
—
—
316
Azithromycin Tablets I.P.
Composition
Standard
Quantity
Each film coated tablet contains:
Azithromycin Dihydrate (eq. to Azithromycin Anhydrous)
I.P.
500 mg
Excipients
—
q.s.
Approved Colour used
—
—
317
Azithromycin Tablets I.P.
Composition
Standard
Quantity
Each film coated tablet contains:
Azithromycin Dihydrate (eq. to Azithromycin Anhydrous)
I.P.
250 mg
Excipients
—
q.s.
Approved Colour used
—
—
318
Ferrous Ascorbate, Folic acid and Zinc Sulphate Monohydrate Tablets
Composition
Standard
Quantity
Each film coated tablet contains:
Ferrous Ascorbate (eq. to Elemental Iron)
—
100 mg
Folic Acid
I.P.
1.5 mg
Zinc Sulphate Monohydrate (eq. to Elemental Zinc)
I.P.
22.5 mg
Excipients
—
q.s.
Approved Colour used
—
—
319
Aceclofenac, Paracetamol and Thiocolchicoside Tablets
Composition
Standard
Quantity
Each film coated tablet contains:
Aceclofenac
I.P.
100 mg
Paracetamol
I.P.
325 mg
Thiocolchicoside
I.P.
4 mg
Excipients
—
q.s.
Approved Colour used
—
—
320
Ursodeoxycholic Acid Tablets
Composition
Standard
Quantity
Each film coated tablet contains:
Ursodeoxycholic Acid
I.P.
300 mg
Excipients
—
q.s.
Approved Colour used
—
—
321
Aceclofenac, Paracetamol and Serratiopeptidase Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)
Composition
Standard
Quantity
Each film coated tablet contains:
Aceclofenac
I.P.
100 mg
Paracetamol
I.P.
325 mg
Serratiopeptidase
(eq. to enzymatic activity 20,000 units)
(as enteric coated granules)
I.P.
10 mg
Excipients
—
q.s.
Approved Colour used
—
—
322
Aceclofenac, Paracetamol and Serratiopeptidase Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)
Composition
Standard
Quantity
Each film coated tablet contains:
Aceclofenac
I.P.
100 mg
Paracetamol
I.P.
325 mg
Serratiopeptidase
(eq. to enzymatic activity 30,000 units)
(as enteric coated granules)
I.P.
15 mg
Excipients
—
q.s.
Approved Colour used
—
—
323
Aceclofenac, Paracetamol and Chlorzoxazone Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)
Composition
Standard
Quantity
Each film coated tablet contains:
Aceclofenac
I.P.
100 mg
Paracetamol
I.P.
325 mg
Chlorzoxazone
U.S.P.
250 mg
Excipients
—
q.s.
Approved Colour used
—
—
324
Aceclofenac and Paracetamol Tablets
Composition
Standard
Quantity
Each film coated tablet contains:
Aceclofenac
I.P.
100 mg
Paracetamol
I.P.
325 mg
Excipients
—
q.s.
Approved Colour used
—
—
325
Aceclofenac and Thiocolchicoside Tablets
Composition
Standard
Quantity
Each film coated tablet contains:
Aceclofenac
I.P.
100 mg
Thiocolchicoside
I.P.
4 mg
Excipients
—
q.s.
Approved Colour used
—
—
326
Telmisartan and Amlodipine Besilate Tablets I.P
Composition
Standard
Quantity
Each uncoated tablet contains:
Telmisartan
I.P.
40 mg
Amlodipine Besilate eq. to Amlodipine
I.P.
5 mg
Excipients
—
q.s.
Approved Colour used
—
—
327
Etoricoxib and Thiocolchicoside Tablets
Composition
Standard
Quantity
Each film coated tablet contains:
Etoricoxib
I.P.
60 mg
Thiocolchicoside
I.P.
4 mg
Excipients
—
q.s.
Approved Colour used
—
—
328
Montelukast and Levocetirizine Tablets I.P
Composition
Standard
Quantity
Each film coated tablet contains:
Montelukast Sodium eq. to Montelukast
I.P.
10 mg
Levocetirizine Hydrochloride
I.P.
5 mg
Excipients
—
q.s.
Approved Colour used
—
—
329
Alpha Lipoic Acid, Folic Acid, Methylcobalamin, Pyridoxine HCl and Vitamin D3 Tablets
Composition
Standard
Quantity
Each film coated tablet contains:
Alpha Lipoic Acid
USP
100 mg
Folic Acid
I.P
1.5 mg
Methylcobalamin
I.P
1500 mcg
Pyridoxine Hydrochloride
I.P
3 mg
Vitamin D3
I.P
1000 IU
Excipients
—
q.s.
Approved Colour used
—
—
330
Paracetamol, Phenylephrine HCl, Diphenhydramine HCl and Caffeine Tablets
Composition
Standard
Quantity
Each chewable film-coated tablet contains :
Fexofenadine Hydrochloride
I.P.
120 mg
Montelukast Sodium eq. to Montelukast
I.P.
10 mg
Excipients
q.s.
Approved Colour used
331
Levetiracetam Tablets I.P 500 mg
Composition
Standard
Quantity
Each film coated tablet contains:
Levetiracetam
I.P
500 mg
Excipients
—
q.s.
Approved colour used
—
—
332
Ketoconazole Tablets I.P 200mg
Composition
Standard
Quantity
Each film coated tablet contains:
Ketoconazole
I.P
200 mg
Excipients
—
q.s.
Approved colour used
—
—
333
Aceclofenac & Drotaverine HCl Tablets
Composition
Standard
Quantity
Each film coated tablet contains:
Aceclofenac
I.P
100 mg
Drotaverine Hydrochloride
I.P
80 mg
Excipients
—
q.s.
Approved Colour used
—
—
334
Etodolac and Paracetamol Tablets
Composition
Standard
Quantity
Each film coated tablet contains:
Etodolac
I.P
400 mg
Paracetamol
I.P
325 mg
Excipients
—
q.s.
Approved Colour used
—
—
335
Amisulpiride Tablets I.P 100 mg
Composition
Standard
Quantity
Each film coated tablet contains:
Amisulpride
I.P
100 mg
Excipients
—
q.s.
Approved colour used
—
—
336
Etodolac ER Tablets 400MG
Composition
Standard
Quantity
Each film coated extended release tablet contains:
Etodolac
I.P
400 mg
Excipients
—
q.s.
Approved Colour used
—
—
337
Nimesulide Tablets (Not to be used for children below 12 years of age)
Composition
Standard
Quantity
Each uncoated tablet contains :
Nimesulide
B.P.
100 mg
Excipients
q.s.
Approved Colour used
338
Methylcobalamin, Alpha Lipoic Acid, Inositol, Folic Acid, Chromium Polynicotinate, Selenium Dioxide and Benfotiamine Capsules
Ingredient
Standard
Quantity
Methylcobalamin
I.P
1500 mcg
Alpha Lipoic Acid
USP
100 mg
Inositol
USP
100 mg
Folic Acid
I.P
1.5 mg
Chromium Polynicotinate
USP
200 mcg
Selenium Dioxide
B.P
55 mcg
Benfotiamine
USP
150 mg
Excipients
—
q.s.
Approved colour used in empty capsule shells
—
—